Published on
Monday, January 14, 2013
Healthcare/biotech funds
ended the year with net inflows of $1.7 billion, even though $755 million
exited these funds in 4Q12. The NYSE Healthcare Index was unchanged in 4Q12,
but was up 12% for the year. The BioCentury 100 Index was down 4% last quarter,
but was up 26% for 2012. December fund flows figure is provisional. Source:
EPFR Global
